EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Dual Role of Uric Acid: Pathological Implications Across Chronic Diseases and Current Approaches to Hyperuricemia Management

Aiza Zehra, Ayeeza Asghar, Sarah Ali, Muhammad Umair Khalid, Syed Imran Ali Shah

Discoveries · 30.06.2026 · 14 (2) · e231

DOI: 10.15190/d.2026.10 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Discoveries, online erschienen am 30.06.2026. Verfasst von Aiza Zehra und 4 weiteren Autor:innen. Beteiligte Einrichtung: CMH Lahore Medical University, Lahore, Pakistan. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uric acid is the end product of purine metabolism and plays a dichotomous role in the human body. On one hand, it exerts antioxidant and neuroprotective effects; on the other hand, chronic hyperuricemia has been strongly associated with diseases beyond gout, affecting the cardiovascular, renal, metabolic, autoimmune, and central nervous systems (CNS). Excess uric acid promotes oxidative stress, endothelial damage, neurodegeneration, inflammasome activation, and impairs energy metabolism. It exacerbates autoimmune diseases, such as Systemic Lupus Erythematosus (SLE) and antiphospholipid syndrome (APS), by increasing inflammatory and oxidative damage, leading to greater end-organ damage. The British Society for Rheumatology, European League Against Rheumatism, American College of Rheumatology, and National Institute for Health and Care Excellence (NICE) have all established a “treat-to-target” approach for hyperuricemia with serum urate levels below 6 mg/dL and below 5 mg/dL in severe cases. Allopurinol and Febuxostat, xanthine oxidase inhibitors, are used as first-line pharmacological therapies for the treatment of hyperuricemia, whereas uricosurics and Interleukin-1 (IL-1) inhibitors are preferred in cases of refractory hyperuricemia. Lifestyle modifications, such as the Dietary Approaches to Stop Hypertension (DASH) diet, weight reduction, and smoking cessation, are also recommended for the long-term management of the disease. Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors, selective urate transport inhibitors, and plant-derived anti-inflammatory compounds have emerged as new treatments with promising responses. This review synthesizes the current literature on the multifaceted role of uric acid and emphasizes its systemic implications in chronic diseases. It also outlines the already established management options and new innovative therapies for managing this disease. Understanding this dichotomous role is essential for adopting a precise management approach that balances the protective and pathological effects of uric acid.

Schlagwörter

Stichwörter der Autor:innen

CDKUric acidautoimmune disorderscardiovascular diseasechronic diseaseschronic kidney diseasehyperuricemiainflammation.oxidative stresstherapeutic interventions

Autor:innen und Institutionen

  • CMH Lahore Medical University, Lahore, Pakistan.
  • Department of Biochemistry, Azra Naheed Medical Colege, Faculty of Medical Sciences, Superior University, Pakistan.

Zitieren

APA

Zehra, A., Asghar, A., Ali, S., Khalid, M. U., & Shah, S. I. A. (2026). The Dual Role of Uric Acid: Pathological Implications Across Chronic Diseases and Current Approaches to Hyperuricemia Management. Discoveries, 14(2), e231. https://doi.org/10.15190/d.2026.10

Vancouver

Zehra A, Asghar A, Ali S, Khalid MU, Shah SIA. The Dual Role of Uric Acid: Pathological Implications Across Chronic Diseases and Current Approaches to Hyperuricemia Management. Discoveries. 2026;14(2):e231. doi:10.15190/d.2026.10

BibTeX
@article{Zehra2026,
  author = {Zehra, Aiza and Asghar, Ayeeza and Ali, Sarah and Khalid, Muhammad Umair and Shah, Syed Imran Ali},
  title = {The Dual Role of Uric Acid: Pathological Implications Across Chronic Diseases and Current Approaches to Hyperuricemia Management},
  journal = {Discoveries},
  year = {2026},
  volume = {14},
  number = {2},
  pages = {e231},
  doi = {10.15190/d.2026.10}
}
Kostenlos starten →